Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$290,335,727
+$84,865,852 QoQ
Shares Held
2,259,422
+32.3% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#105
of 3,792 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026APG Asset Management N.V. holds $2,708,459,664 across 8 Drug Manufacturers - General names. MRK ranks #3 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,210,321 | $1,451,695,438 | |
| 2 | ABBV |
AbbVie Inc.
|
1,613,385 | $405,992,201 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
2,259,422 | $290,335,727 | |
| 4 | AMGN |
Amgen Inc
|
516,533 | $187,046,929 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,197,619 | $151,307,184 | |
| 6 | PFE |
Pfizer Inc
|
4,179,623 | $100,645,321 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,691,386 | $97,457,661 | |
| 8 | BIIB |
Biogen Inc.
|
110,984 | $23,979,203 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $290,335,727 | 2,259,422 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $205,469,875 | 1,708,121 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $173,989,411 | 1,652,949 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $149,464,894 | 1,780,828 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $150,542,055 | 1,901,744 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $241,022,923 | 2,685,193 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $264,168,642 | 2,655,495 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $74,843,080 | 659,062 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $370,589,357 | 2,993,452 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $433,091,568 | 3,282,240 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $369,685,402 | 3,390,987 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $329,008,227 | 3,195,806 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $426,729,528 | 3,698,150 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $407,369,118 | 3,829,017 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $459,061,394 | 4,137,552 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $174,223,601 | 2,023,033 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $252,833,920 | 2,773,214 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $231,998,344 | 2,827,524 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $234,860,520 | 3,064,464 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $229,077,313 | 3,049,891 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $251,305,278 | 3,231,391 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $262,553,417 | 3,405,802 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $360,230,268 | 4,403,795 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $335,227,815 | 4,041,322 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $332,711,464 | 4,302,487 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $326,720,265 | 4,246,431 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||